ENERGISED: mHealth Intervention to Increase Physical Activity in Prediabetes and Type 2 Diabetes

Sponsor
Charles University, Czech Republic (Other)
Overall Status
Recruiting
CT.gov ID
NCT05351359
Collaborator
University of Hradec Kralove (Other), St George's, University of London (Other), University of Leicester (Other), University Ghent (Other)
340
1
2
25.2
13.5

Study Details

Study Description

Brief Summary

Sedentary behaviour has a detrimental effect on the mortality, morbidity, and well-being of patients with type 2 diabetes and prediabetes, and general practitioners should advise patients on how to self-monitor and increase their physical activity. The emergence of mobile health (mHealth) technologies unlocks the potential to further improve physical behaviour using an innovative "just-in-time" adaptive approach whereby behavioural support is provided in real-time, based on data from wearable sensors. Thus, the investigators aim to evaluate the effect of a just-in-time mHealth intervention administered by general practitioners on the physical activity and sedentary behaviour of patients with type 2 diabetes and prediabetes. A total of 340 patients will be recruited from 20 general practices across the Czech Republic and randomly assigned to either an active control or intervention group. Both groups will receive brief physical activity advice from their general practitioners and a Fitbit fitness tracker to self-monitor their daily steps, but the intervention group will also receive a mHealth-enabled just-in-time adaptive intervention and regular monthly phone counselling in the first 6 months. The mHealth intervention will be delivered using a custom-developed system (HealthReact) connected to the Fitbit that will trigger just-in-time text messages. For example, a prompt to take a break from sedentary behaviour will be triggered after 30 sedentary minutes or a motivational message with a specific goal to take more steps will be triggered when the total step count is too low. The primary outcome will be the change in daily step count at 6 months, other outcomes include changes in other physical behaviour measures, blood tests, anthropometry and patient-reported outcomes at 6 and 12 months. If the intervention is effective, this study will provide a model of health prevention that can be directly implemented and commissioned within primary care using existing infrastructure.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: mHealth
  • Behavioral: phone counselling
  • Behavioral: Fitbit tracker
  • Behavioral: brief advice
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
340 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
mHealth Intervention Delivered in General Practice to Increase Physical Activity and Reduce Sedentary Behaviour of Patients With Prediabetes and Type 2 Diabetes
Actual Study Start Date :
Apr 25, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Active control

The patients from the active control group will receive brief physical activity advice from their general practitioners at baseline, and they will also receive the Fitbit tracker to self-monitor their daily steps.

Behavioral: Fitbit tracker
Fitbit Inspire 2 will be provided by the general practitioner to study participants at the start of the study to enable objective self-monitoring of physical activity.

Behavioral: brief advice
A brief advice will be provided by the general practitioner at the start of the study.

Experimental: Intervention

The patients in the intervention group will be exposed to the same procedures as those from the active control group, but will also receive a mHealth-enabled just-in-time adaptive intervention and regular monthly phone counselling in the first 6 months.

Behavioral: mHealth
A mHealth-enabled just-in-time adaptive intervention that is based on the HealthReact system developed by the participating centre at the Faculty of Science of the University of Hradec Kralove. The HealthReact system consists of a server-side application that is connected to the Fitbit server. As such, the system allows for just-in-time text messages triggered by pre-defined context as recorded by the Fitbit wearable monitor. For example, a prompt to take a break from sedentary behaviour can be triggered after 30 sedentary minutes, a suggestion to increase walking cadence can be triggered when continuous, but slow walking is detected, or a motivational message with a specific goal to take more steps to reach their usual daily step count can be triggered when the total daily steps are too low. The mHealth component will be delivered for the entire duration of the study (i.e., 12 months).

Behavioral: phone counselling
Regular monthly phone calls by trained counsellors support participants in their effort to increase physical activity and reduce sedentary behaviours. The counsellors will use various behaviour change techniques, such as goal-setting, feedback, action planning, etc. The phone counselling will be provided during the first six months, i.e. 6 phone calls will be delivered.

Behavioral: Fitbit tracker
Fitbit Inspire 2 will be provided by the general practitioner to study participants at the start of the study to enable objective self-monitoring of physical activity.

Behavioral: brief advice
A brief advice will be provided by the general practitioner at the start of the study.

Outcome Measures

Primary Outcome Measures

  1. step count [from baseline to six-month assessment]

    change in daily step count

Secondary Outcome Measures

  1. chair-stand test [at 6 and 12 months]

    functional 30s chair-stand test

  2. HbA1c [at 6 and 12 months]

    haemoglobin A1c

  3. glycemia [at 6 and 12 months]

    fasting plasma glucose

  4. lipid profile [at 12 months]

    total cholesterol, LDL cholesterol, HDL cholesterol, triacylglycerids

  5. step count [at 12 months]

    change in daily step count

  6. physical behaviour - average acceleration [at 6 and 12 months]

    metric of physical activity volume

  7. physical behaviour - intensity gradient [at 6 and 12 months]

    metric of physical activity intensity

  8. sedentary time [at 6 and 12 months]

    time per day spent sedentary (in minutes)

  9. sedentary bouts [at 6 and 12 months]

    time per day (in minutes) spent sedentary in bouts of 30 mins and longer

  10. walking cadence [at 6 and 12 months]

    cadence (steps/min) in 5 (non-consecutive) highest-cadence minutes

  11. blood pressure [at 6 and 12 months]

    systolic and diastolic blood pressure

  12. Hospital Anxiety and Depression Scale (HADS) [at 6 and 12 months]

    symptoms of anxiety and depression: 14 items on a scale 0-3 (a higher score means a worse outcome)

  13. Short Form Survey (SF-12) [at 6 and 12 months]

    measure of health-related quality of life: 12 items using various scales converted to a score 0-100 (a higher score means a better outcome)

  14. body mass index [at 6 and 12 months]

    weigh in kilograms divided by height in meters squared

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of prediabetes or T2DM according to the Czech guidelines for GPs on diabetes mellitus1 and prediabetes2, i.e. fasting plasma glucose 5.6-6.9 mmol/l, or 2-h plasma glucose of 7.8-11.0 mmol/l after ingestion of 75 g of oral glucose load for the diagnosis of prediabetes, and fasting plasma glucose ≥ 7.0 mmol/l, or 2-h plasma glucose ≥ 11.1 mmol/l after ingestion of 75 g of the oral glucose load for the diagnosis of T2DM

  • Age 18 years or older.

  • Registered at a participating general practice.

  • Regular users of a smartphone and willing to use it as part of the study.

  • Written informed consent obtained before any assessment related to the study.

Exclusion Criteria:
  • unable to walk

  • pregnancy

  • taking insulin

  • living in a residential or nursing care home

  • co-morbid conditions that would affect their adherence to the trial procedures

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute of General Practice Prague Czechia

Sponsors and Collaborators

  • Charles University, Czech Republic
  • University of Hradec Kralove
  • St George's, University of London
  • University of Leicester
  • University Ghent

Investigators

  • Study Chair: Bohumil Seifert, MD, PhD, Charles University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tomáš Větrovský, Lecturer, Charles University, Czech Republic
ClinicalTrials.gov Identifier:
NCT05351359
Other Study ID Numbers:
  • ENERGISED
First Posted:
Apr 28, 2022
Last Update Posted:
Jul 27, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2022